Illumina has extended a supply agreement with Foundation until 2023 and developed an automated metagenomics workflow with PerkinElmer.
Sanquin provided input to the design of Abbott's next-generation Alinity s system and served as a clinical testing site during the development process.
OpGen recently launched the first Acuitas test, which is designed to detect the most common bacterial causes of complicated urinary tract infections.
Sysmex said that in 2018, it will replace LifeLabs' hematology analyzers at 12 sites throughout British Columbia and Ontario and provide scalable solutions.
Chembio's point-of-care DPP Zika System, including an IgM/IgG assay and micro reader, provides quantitative results in 15 minutes from 10μl of fingertip blood.
OraSure noted that the devices allow ambient temperature transportation and storage of a liquid sample to enable high throughput automation in a laboratory.
Grifols also said that it is building a new manufacturing facility in the Bay area.
The device will be used with MDxHealth's SelectMDx for Prostate Cancer IVD kit, which will launch later this year.
Under the terms of the agreement, Natera will develop in vitro diagnostic products for oncology and pay Illumina milestone payments and royalties.